Nick Kadysh is the Founder of PharmAla Biotech, dedicated to the manufacture of MDMA and MDXX class molecules for pharmaceutical research.He spent the majority of his career helping companies navigate complex regulatory risk in Healthcare. After a career in Government at the Federal and Provincial levels, he has served as Head of Corporate Affairs at JUUL Labs Canada, Government Affairs & Public Leader at GE Healthcare and Director of Public Affairs for Red Bull Canada. https://pharmala.ca